Antibiotic alternatives: The substitution of antibiotics in animal husbandry?

Frontiers in Microbiology

Volumn 5, Issue MAY, 2014, Pages

  Cheng, Guyue ^a   Hao, Haihong ^a   Xie, Shuyu ^a   Wang, Xu ^a   Dai, Menghong ^a   Huang, Lingli ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antibiotic alternatives; Antibiotics; Application; Limitation

Indexed keywords

ALGINATE LYASE; ANTHRAX TOXIN; ANTIBIOTIC AGENT; BACTERIAL VACCINE; BACTERIOCIN; BACTERIOPHAGE VIRION ASSOCIATED PEPTIDOGLYCAN HYDROLASE; CISPLATIN; DEOXYRIBONUCLEASE; DNA VACCINE; ENDOLYSIN; ENZYME; FLEROXACIN; GLUCAN SYNTHASE; GLUCOSE OXIDASE; HYDROXAMIC ACID; IMMUNOMODULATING AGENT; IMMUNOSTIMULATING AGENT; INACTIVATED VACCINE; LYSOZYME; MELITTIN; PHYTASE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYPEPTIDE ANTIBIOTIC AGENT; POLYSACCHARIDE HYDROLASE; PREBIOTIC AGENT; PROBIOTIC AGENT; PROCLIN; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL FOOD; ANIMAL HUSBANDRY; ANTHRAX; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIOPHAGE; BIOFILM; DRUG ABUSE; DRUG SAFETY; DRUG TARGETING; NONHUMAN; QUORUM SENSING; TYPE III SECRETION SYSTEM; VIROTHERAPY;

EID: 84904887970     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00217     Document Type: Article

References (179)

1. Aarestrup, F. M., Bager, F., Jensen, N. E., Madsen, M., Meyling, A., and Wegener, H. C. (1998). Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS 106, 606-622. doi: 10.1111/j.1699-0463.1998.tb01391.x
2. Abreu, A. C., McBain, A. J., and Simoes, M. (2012). Plants as sources of new antimicrobials and resistance-modifying agents. Nat. Prod. Rep. 29, 1007-1021. doi: 10.1039/c2np20035j
3. Adeola, O., and Cowieson, A. J. (2011). Board-invited review: opportunities and challenges in using exogenous enzymes to improve nonruminant animal production. J. Anim. Sci. 89, 3189-3218. doi: 10.2527/jas.2010-3715
4. Alexandre, Y., Le Blay, G., Boisrame-Gastrin, S., Le Gall, F., Hery-Arnaud, G., Gouriou, S., et al. (2014). Probiotics: a new way to fight bacterial pulmonary infections? Med. Mal. Infect. 44, 9-17. doi: 10.1016/j.medmal.2013.05.001
5. Alipour, M., Suntres, Z. E., and Omri, A. (2009). Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 64, 317-325. doi: 10.1093/jac/dkp165
6. Allen, H. K., Levine, U. Y., Looft, T., Bandrick, M., and Casey, T. A. (2013). Treatment, promotion, commotion: antibiotic alternatives in food-producing animals. Trends Microbiol. 21, 114-119. doi: 10.1016/j.tim.2012.11.001
7. Amara, N., Krom, B. P., Kaufmann, G. F., and Meijler, M. M. (2011). Macromolecular inhibition of quorum sensing: enzymes, antibodies, and beyond. Chem. Rev. 111, 195-208. doi: 10.1021/cr100101c
8. Anadon, A., Abroix Arzo, M., Bories, G., Brantom, P., Brufau de Barbera, J., Chesson, A., et al. (2005). Opinion of the FEEDAP Panel on the safety and efficacy of the product Farmatan for rabbits and piglets. EFSA J. 222, 1-20.
9. Anadon, A., Martinez-Larranaga, M. R., and Aranzazu Martinez, M. (2006). Probiotics for animal nutrition in the European Union. Regulation and safety assessment. Regul. Toxicol. Pharmacol. 45, 91-95. doi: 10.1016/j.yrtph.2006.02.004
10. Andersson, H., Asp, N.-G., Bruce, A., Roos, S., Wadstrom, T., and Wold, A. (2001). Health effects of probiotics and prebiotics: a literature review on human studies. Scand. J. Nutr. 45, 58-75.
11. Apajalahti, J., Kettunen, A., and Graham, H. (2004). Characteristics of the gastrointestinal microbial communities, with special reference to chickens. World Poult. Sci. J. 52, 223-232. doi: 10.1079/WPS20040017
12. Badia, R., Lizardo, R., Martinez, P., and Brufau, J. (2013). Oligosaccharide structure determines prebiotic role of beta-galactomannan against Salmonella enterica ser. Typhimurium in vitro. Gut Microbes 4, 72-75. doi: 10.4161/gmic.22728
13. Bagley, M. C., Dale, J. W., Merritt, E. A., and Xiong, X. (2005). Thiopeptide antibiotics. Chem. Rev. 105, 685-714. doi: 10.1021/cr0300441
14. Balish, E., and Wagner, R. D. (1998). Probiotic bacteria for prophylaxis and therapy of candidiasis. Rev. Iberoam. Micol. 15, 261-264.
15. Barrow, P. A. (2007). Salmonella infections: immune and non-immune protection with vaccines. Avian Pathol. 36, 1-13. doi: 10.1080/03079450601113167
16. Bedford, M. R., and Cowieson, A. J. (2012). Exogenous enzymes and their effects on intestinal microbiology. Anim. Feed Sci. Technol. 173, 76-85. doi: 10.1016/j.anifeedsci.2011.12.018
17. Berchieri, A. Jr., Lovell, M. A., and Barrow, P. A. (1991). The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. 142, 541-549. doi: 10.1016/0923-2508(91)90187-F
18. Bhardwaj, A. K., Vinothkumar, K., and Rajpara, N. (2013). Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance. Recent Pat. Antiinfect. Drug Discov. 8, 68-83. doi: 10.2174/1574891X11308010012
19. Bierbaum, G., and Sahl, H. G. (2009). Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10, 2-18. doi: 10.2174/138920109787048616
20. Bjarnsholt, T., and Givskov, M. (2007). Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362, 1213-1222. doi: 10.1098/rstb.2007.2046
21. Bjarnsholt, T., and Givskov, M. (2008). Quorum sensing inhibitory drugs as next generation antimicrobials: worth the effort? Curr. Infect. Dis. Rep. 10, 22-28. doi: 10.1007/s11908-008-0006-y
22. Borchardt, R. A., and Rolston, K. V. (2013). Antibiotic shortages: effective alternatives in the face of a growing problem. JAAPA 26, 13, 18.
23. Borovan, L. (2004). Plant alkaloids enhance performance of animals and improve the utilizability of amino acids (in Czech). Krmivarstvi 6, 36-37.
24. Borriello, S. P., Hammes, W. P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., et al. (2003). Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect. Dis. 36, 775-780. doi: 10.1086/368080
25. Bourlioux, P. (2013). Which alternatives are at our disposal in the anti-infectious therapeutics face to multi-drug resistant bacteria? (article in French). Ann. Pharm. Fr. 71, 150-158. doi: 10.1016/j.pharma.2013.02.005
26. Brabban, A. D., Hite, E., and Callaway, T. R. (2005). Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer. Foodborne Pathog. Dis. 2, 287-303. doi: 10.1089/fpd.2005.2.287
27. Bricknell, I., and Dalmo, R. A. (2005). The use of immunostimulants in fish larval aquaculture. Fish Shellfish Immunol. 19, 457-472. doi: 10.1016/j.fsi.2005.03.008
28. Brussow, H. (2007). "Phage therapy: the Western perspective," in Bacteriophage: Genetics and Microbiology, eds S. McGrath and D. van Sinderen (Norfolk: Caister Academic Press), 159-192.
29. Buckley, A. M., Wang, J., Hudson, D. L., Grant, A. J., Jones, M. A., Maskell, D. J., et al. (2010). Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry. Vaccine 28, 1094-1105. doi: 10.1016/j.vaccine.2009.10.018
30. Burrowes, B., Harper, D. R., Anderson, J., McConville, M., and Enright, M. C. (2011). Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev. Antiinfect. Ther. 9, 775-785. doi: 10.1586/eri.11.90
31. Caldentey, J., and Bamford, D. H. (1992). The lytic enzyme of the Pseudomonas phage phi 6. Purification and biochemical characterization. Biochim. Biophys. Acta 1159, 44-50. doi: 10.1016/0167-4838(92)90073-M
32. Callaway, T. R., Edrington, T. S., Brabban, A., Kutter, B., Karriker, L., Stahl, C., et al. (2011). Evaluation of phage treatment as a strategy to reduce Salmonella populations in growing swine. Foodborne Pathog. Dis. 8, 261-266. doi: 10.1089/fpd.2010.0671
33. Carlton, R. M. (1999). Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. (Warsz.) 47, 267-274.
34. Castanon, J. I. (2007). History of the use of antibiotic as growth promoters in European poultry feeds. Poult. Sci. 86, 2466-2471. doi: 10.3382/ps.2007-00249
35. Chen, L., and Wen, Y. M. (2011). The role of bacterial biofilm in persistent infections and control strategies. Int. J. Oral Sci. 3, 66-73. doi: 10.4248/IJOS11022
36. Chun, C. K., Ozer, E. A., Welsh, M. J., Zabner, J., and Greenberg, E. P. (2004). Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 101, 3587-3590. doi: 10.1073/pnas.0308750101
37. Clatworthy, A. E., Pierson, E., and Hung, D. T. (2007). Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3, 541-548. doi: 10.1038/nchembio.2007.24
38. Cogliani, C., Goossens, H., and Greko, C. (2011). Restricting antimicrobial use in food animals: lessons from Europe. Microbe 6, 274-279.
39. European Commission. (2003). Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition. Off. J. Eur. Union 268, 29-43.
40. Cooper, M. A., and Shlaes, D. (2011). Fix the antibiotics pipeline. Nature 472, 32. doi: 10.1038/472032a
41. Cooper, R. A. (2013). Inhibition of biofilms by glucose oxidase, lactoperoxidase and guaiacol: the active antibacterial component in an enzyme alginogel. Int. Wound J. doi: 10.1111/iwj.12083 [Epub ahead of print].
42. Costa, L. B., Panhoza Tse, M. L., and Miyada, V. S. (2007). Herbal extracts as alternatives to antimicrobial growth for weanling pigs. Braz. J. Anim. Sci. 36, 589-595. doi: 10.1590/S1516-35982007000300011
43. Cotter, P. D., Hill, C., and Ross, R. P. (2005). Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3, 777-788. doi: 10.1038/nrmicro1273
44. Cotter, P. D., Ross, R. P., and Hill, C. (2013). Bacteriocins - a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105. doi: 10.1038/nrmicro2937
45. Courchesne, N. M., Parisien, A., and Lan, C. Q. (2009). Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat. Biotechnol. 3, 37-45. doi: 10.2174/187220809787172678
46. Cross, D. E., Mcdevitt, R. M., Hillman, K., and Acamovic, T. (2007). The effect of herbs and their associated essential oils on performance, dietary digestibility and gut microflora in chickens from 7 to 28 days of age. Br. Poult. Sci. 48, 496-506. doi: 10.1080/00071660701463221
47. Crouch, C. F., Withanage, G. S., de Haas, V., Etore, F., and Francis, M. J. (2010). Safety and efficacy of a maternal vaccine for the passive protection of broiler chicks against necrotic enteritis. Avian Pathol. 39, 489-497. doi: 10.1080/03079457.2010.517513
48. Dabrowska, K., Switala-Jelen, K., Opolski, A., Weber-Dabrowska, B., and Gorski, A. (2005). Bacteriophage penetration in vertebrates. J. Appl. Microbiol. 98, 7-13. doi: 10.1111/j.1365-2672.2004.02422.x
49. del Castillo, F. J., del Castillo, I., and Moreno, F. (2001). Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase. J. Bacteriol. 183, 2137-2140. doi: 10.1128/JB.183.6.2137-2140.2001
50. de Vrese, M., and Schrezenmeir, J. (2008). Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111, 1-66. doi: 10.1007/10_2008_097
51. Desin, T. S., Koster, W., and Potter, A. A. (2013). Salmonella vaccines in poultry: past, present and future. Expert Rev. Vaccines 12, 87-96. doi: 10.1586/erv.12.138
52. Draper, L. A., Grainger, K., Deegan, L. H., Cotter, P. D., Hill, C., and Ross, R. P. (2009). Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol. Microbiol. 71, 1043-1054. doi: 10.1111/j.1365-2958.2008.06590.x
53. Drulis-Kawa, Z., Majkowska-Skrobek, G., Maciejewska, B., Delattre, A. S., and Lavigne, R. (2012). Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr. Protein Pept. Sci. 13, 699-722. doi: 10.2174/138920312804871193
54. Fenton, M., Ross, P., McAuliffe, O., O'Mahony, J., and Coffey, A. (2010). Recombinant bacteriophage lysins as antibacterials. Bioeng. Bugs 1, 9-16. doi: 10.4161/bbug.1.1.9818
55. Field, D., Hill, C., Cotter, P. D., and Ross, R. P. (2011). The dawning of a 'Golden era' in lantibiotic bioengineering. Mol. Microbiol. 78, 1077-1087. doi: 10.1111/j.1365-2958.2010.07406.x
56. Fischetti, V. A. (2005). Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol. 13, 491-496. doi: 10.1016/j.tim.2005.08.007
57. Fournier, D., Chirouze, C., Leroy, J., Cholley, P., Talon, D., Plesiat, P., et al. (2013). Alternatives to carbapenems in ESBL-producing Escherichia coli infections. Med. Mal. Infect. 43, 62-66. doi: 10.1016/j.medmal.2013.01.006
58. Frana, T. S., Carlson, S. A., Rauser, D. C., Jones, B. D., Fergen, B. J., and Griffith, R. W. (2004). Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype Typhimurium in pigs. Am. J. Vet. Res. 65, 1616-1620. doi: 10.2460/ajvr.2004.65.1616
59. Francis, D. H., and Willgohs, J. A. (1991). Evaluation of a live avirulent Escherichia coli vaccine for K88+, LT+ enterotoxigenic colibacillosis in weaned pigs. Am. J. Vet. Res. 52, 1051-1055.
60. Gaggia, F., Mattarelli, P., and Biavati, B. (2010). Probiotics and prebiotics in animal feeding for safe food production. Int. J. Food Microbiol. 141(Suppl. 1), S15-S28. doi: 10.1016/j.ijfoodmicro.2010.02.031
61. Gast, R. K. (2007). Serotype-specific and serotype-independent strategies for preharvest control of food-borne Salmonella in poultry. Avian Dis. 51, 817-828. doi: 10.1637/8090-081807.1
62. Geisen, R. (1999). Inhibition of food-related pathogenic bacteria by god-transformed Penicillium nalgiovense strains. J. Food Prot. 62, 940-943.
63. Gertsch, J., Viveros-Paredes, J. M., and Taylor, P. (2011). Plant immunostimulants - scientific paradigm or myth? J. Ethnopharmacol. 136, 385-391. doi: 10.1016/j.jep.2010.06.044
64. Giannenas, A. I., Florou-Paneri, P., Papazahariadou, M., Christaki, E., Botsoglou, N. A., and Spais, A. B. (2003). Dietary oregano essential oil supplementation on performance of broilers challenged with Eimeria tenella. Arch. Anim. Nutr. 57, 99-106. doi: 10.1080/0003942031000107299
65. Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A., and Roberfroid, M. B. (2004). Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17, 259-275. doi: 10.1079/NRR200479
66. Gorski, A., Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B., Lobocka, M., Fortuna, W., et al. (2009). Bacteriophage therapy for the treatment of infections. Curr. Opin. Investig. Drugs 10, 766-774.
67. Guani-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., and Teran, L. M. (2010). Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 135, 1-11. doi: 10.1016/j.clim.2009.12.004
68. Harvey, A. L. (2008). Natural products in drug discovery. Drug Discov. Today 13, 894-901. doi: 10.1016/j.drudis.2008.07.004
69. Hashemi, S. R., and Davoodi, H. (2011). Herbal plants and their derivatives as growth and health promoters in animal nutrition. Vet. Res. Commun. 35, 169-180. doi: 10.1007/s11259-010-9458-2
70. Hashemi, S. R., and Davoodi, H. (2010). Phytogenics as new class of feed additive in poultry industry. J. Anim. Vet. Adv. 9, 2295-2304. doi: 10.3923/javaa.2010.2295.2304
71. Hatch, R. A., and Schiller, N. L. (1998). Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42, 974-977.
72. Haygreen, L., Davison, F., and Kaiser, P. (2005). DNA vaccines for poultry: the jump from theory to practice. Expert Rev. Vaccines 4, 51-62. doi: 10.1586/14760584.4.1.51
73. Hentzer, M., Wu, H., Andersen, J. B., Riedel, K., Rasmussen, T. B., Bagge, N., et al. (2003). Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22, 3803-3815. doi: 10.1093/emboj/cdg366
74. Hoiby, N., Bjarnsholt, T., Givskov, M., Molin, S., and Ciofu, O. (2010). Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35, 322-332. doi: 10.1016/j.ijantimicag.2009.12.011
75. Hudson, D. L., Layton, A. N., Field, T. R., Bowen, A. J., Wolf-Watz, H., Elofsson, M., et al. (2007). Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors. Antimicrob. Agents Chemother. 51, 2631-2635. doi: 10.1128/AAC.01492-06
76. Huff, W. E., Huff, G. R., Rath, N. C., Balog, J. M., and Donoghue, A. M. (2005). Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poult. Sci. 84, 655-659. doi: 10.1093/ps/84.4.655
77. Hung, D. T., Shakhnovich, E. A., Pierson, E., and Mekalanos, J. J. (2005). Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670-674. doi: 10.1126/science.1116739
78. Huyghebaert, G., Ducatelle, R., and Van Immerseel, F. (2011). An update on alternatives to antimicrobial growth promoters for broilers. Vet. J. 187, 182-188. doi: 10.1016/j.tvjl.2010.03.003
79. Izano, E. A., Amarante, M. A., Kher, W. B., and Kaplan, J. B. (2008). Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl. Environ. Microbiol. 74, 470-476. doi: 10.1128/AEM.02073-07
80. Johnson, R. P., Gyles, C. L., Huff, W. E., Ojha, S., Huff, G. R., Rath, N. C., et al. (2008). Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. Anim. Health Res. Rev. 9, 201-215. doi: 10.1017/S1466252308001576
81. Kak, V., Sundareshan, V., Modi, J., and Khardori, N. M. (2012). Immunotherapies in infectious diseases. Med. Clin. North Am. 96, 455-474. doi: 10.1016/j.mcna.2012.04.002
82. Kalia, V. C., and Purohit, H. J. (2011). Quenching the quorum sensing system: potential antibacterial drug targets. Crit. Rev. Microbiol. 37, 121-140. doi: 10.3109/1040841X.2010.532479
83. Kaplan, J. B., Ragunath, C., Velliyagounder, K., Fine, D. H., and Ramasubbu, N. (2004). Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 48, 2633-2636. doi: 10.1128/AAC.48.7.2633-2636.2004
84. Karou, D., Savadogo, A., Canini, A., Yameogo, S., Montesano, C., Simpore, J., et al. (2006). Antibacterial activity of alkaloids from Sida acuta. Afr. J. Biotechnol. 5, 195-200.
85. Kiedrowski, M. R., and Horswill, A. R. (2011). New approaches for treating staphylococcal biofilm infections. Ann. N. Y. Acad. Sci. 1241, 104-121. doi: 10.1111/j.1749-6632.2011.06281.x
86. Kolida, S., and Gibson, G. R. (2011). Synbiotics in health and disease. Annu. Rev. Food Sci. Technol. 2, 373-393. doi: 10.1146/annurev-food-022510-133739
87. Kramer, N. E., van Hijum, S. A., Knol, J., Kok, J., and Kuipers, O. P. (2006). Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob. Agents Chemother. 50, 1753-1761. doi: 10.1128/AAC.50.5.1753-1761.2006
88. Kumon, H. (2000). Management of biofilm infections in the urinary tract. World J. Surg. 24, 1193-1196. doi: 10.1007/s002680010203
89. Lavigne, R., Briers, Y., Hertveldt, K., Robben, J., and Volckaert, G. (2004). Identification and characterization of a highly thermostable bacteriophage lysozyme. Cell. Mol. Life Sci. 61, 2753-2759. doi: 10.1007/s00018-004-4301-y
90. Lee, H., and Kim, H. Y. (2011). Lantibiotics, class I bacteriocins from the genus Bacillus. J. Microbiol. Biotechnol. 21, 229-235.
91. Lee, K. W., Everts, H., Kappert, H. J., Wouterse, H., Frehner, M., and Beynen, A. C. (2004). Cinnamaldehyde, but not thymol, counteracts the carboxymethyl cellulose-induced growth depression in female broiler chickens. Int. J. Poult. Sci. 3, 608-612. doi: 10.3923/ijps.2004.608.612
92. Leonard, B. C., Affolter, V. K., and Bevins, C. L. (2012). Antimicrobial peptides: agents of border protection for companion animals. Vet. Dermatol. 23, 177-e136. doi: 10.1111/j.1365-3164.2012.01037.x
93. Lin, J. (2014). Antibiotic growth promoters enhance animal production by targeting intestinal bile salt hydrolase and its producers. Front. Microbiol. 5:33. doi: 10.3389/fmicb.2014.00033
94. Liu, D., Guo, S., and Guo, Y. (2012a). Xylanase supplementation to a wheat-based diet alleviated the intestinal mucosal barrier impairment of broiler chickens challenged by Clostridium perfringens. Avian Pathol. 41, 291-298. doi: 10.1080/03079457.2012.684089
95. Liu, D., Guo, Y., Wang, Z., and Yuan, J. (2012b). Exogenous lysozyme influences Clostridium perfringens colonization and intestinal barrier function in broiler chickens. Avian Pathol. 39, 17-24. doi: 10.1080/03079450903447404
96. Liu, M., Deora, R., Doulatov, S. R., Gingery, M., Eiserling, F. A., Preston, A., et al. (2002). Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage. Science 295, 2091-2094. doi: 10.1126/science.1067467
97. Loeffler, J. M., Djurkovic, S., and Fischetti, V. A. (2003). Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun. 71, 6199-6204. doi: 10.1128/IAI.71.11.6199-6204.2003
98. Loeffler, J. M., Nelson, D., and Fischetti, V. A. (2001). Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172. doi: 10.1126/science.1066869
99. Low, L. Y., Yang, C., Perego, M., Osterman, A., and Liddington, R. C. (2005). Structure and lytic activity of a Bacillus anthracis prophage endolysin. J. Biol. Chem. 280, 35433-35439. doi: 10.1074/jbc.M502723200
100. Lynch, T. J. (2012). Choosing optimal antimicrobial therapies. Med. Clin. North Am. 96, 1079-1094. doi: 10.1016/j.mcna.2012.08.006
101. Mai, G. T., McCormack, J. G., Seow, W. K., Pier, G. B., Jackson, L. A., and Thong, Y. H. (1993). Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics. Infect. Immun. 61, 4338-4343.
102. Maiques, E., Ubeda, C., Tormo, M. A., Ferrer, M. D., Lasa, I., Novick, R. P., et al. (2007). Role of staphylococcal phage and SaPI integrase in intra- and interspecies SaPI transfer. J. Bacteriol. 189, 5608-5616. doi: 10.1128/JB.00619-07
103. Manzanilla, E. G., Perez, J. F., Martin, M., Kamel, C., Baucells, F., and Gasa, J. (2004). Effect of plant extracts and formic acid on the intestinal equilibrium of early-weaned pigs. J. Anim. Sci. 82, 3210-3218.
104. Marshall, B. M., and Levy, S. B. (2011). Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 24, 718-733. doi: 10.1128/CMR.00002-11
105. Marti, M., Trotonda, M. P., Tormo-Mas, M. A., Vergara-Irigaray, M., Cheung, A. L., Lasa, I., et al. (2010). Extracellular proteases inhibit protein-dependent biofilm formation in Staphylococcus aureus. Microbes Infect. 12, 55-64. doi: 10.1016/j.micinf.2009.10.005
106. Masihi, K. N. (2000). Immunomodulators in infectious diseases; panoply of possibilities. Int. J. Immunopharmacol. 22, 1083-1091. doi: 10.1016/S0192-0561(00)00074-6
107. Mayville, P., Ji, G., Beavis, R., Yang, H., Goger, M., Novick, R. P., et al. (1999). Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc. Natl. Acad. Sci. U.S.A. 96, 1218-1223. doi: 10.1073/pnas.96.4.1218
108. Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., et al. (1996). Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. U.S.A. 93, 3188-3192. doi: 10.1073/pnas.93.8.3188
109. Metlitskaya, A., Kazakov, T., Kommer, A., Pavlova, O., Praetorius-Ibba, M., Ibba, M., et al. (2006). Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic microcin C. J. Biol. Chem. 281, 18033-18042. doi: 10.1074/jbc.M513174200
110. Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., et al. (2012). Clinical aspects of phage therapy. Adv. Virus Res. 83, 73-121. doi: 10.1016/B978-0-12-394438-2.00003-7
111. Millet, S., and Maertens, L. (2011). The European ban on antibiotic growth promoters in animal feed: from challenges to opportunities. Vet. J. 187, 143-144. doi: 10.1016/j.tvjl.2010.05.001
112. Moayeri, M., Wiggins, J. F., Lindeman, R. E., and Leppla, S. H. (2006). Cisplatin inhibition of anthrax lethal toxin. Antimicrob. Agents Chemother. 50, 2658-2665. doi: 10.1128/AAC.01412-05
113. Modesto, M., D'Aimmo, M. R., Stefanini, I., Trevisi, P., De Filippi, S., Casini, L., et al. (2009). A novel strategy to select Bifidobacterium strains and prebiotics as natural growth promoters in newly weaned pigs. Livest. Sci. 122, 248-258. doi: 10.1016/j.livsci.2008.08.017
114. Molloy, E. M., Field, D., O'Connor, P. M., Cotter, P. D., Hill, C., and Ross, R. P. (2013). Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity. PLoS ONE 8:e58530. doi: 10.1371/journal.pone.0058530
115. Moore, C. P. (2004). Immunomodulating agents. Vet. Clin. North Am. Small Anim. Pract. 34, 725-737. doi: 10.1016/j.cvsm.2004.01.002
116. Morales-delaNuez, A., Castro, N., Moreno-Indias, I., Juste, M. C., Sanchez-Macias, D., Briggs, H., et al. (2009). Effects of a reputed immunostimulant on the innate immune system of goat kids. Small Rumin. Res. 85, 23-26. doi: 10.1016/j.smallrumres.2009.06.016
117. Morrissey, J. P., and Osbourn, A. E. (1999). Fungal resistance to plant antibiotics as a mechanism of pathogenesis. Microbiol. Mol. Biol. Rev. 63, 708-724.
118. Mutwiri, G., Gerdts, V., van Drunen Littel-van den Hurk, S., Auray, G., Eng, N., Garlapati, S., et al. (2011). Combination adjuvants: the next generation of adjuvants? Expert Rev. Vaccines 10, 95-107. doi: 10.1586/erv.10.154
119. Namkung, H., Li, M., Gong, J., Yu, H., Cottrill, M., and De Lange, C. F. M. (2004). Impact of feeding blends of organic acids and herbal extracts on growth performance, gut microbiota and digestive function in newly weaned pigs. Can. J. Anim. Sci. 84, 697-704. doi: 10.4141/A04-005
120. Newman, D. J. (2008). Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J. Med. Chem. 51, 2589-2599. doi: 10.1021/jm0704090
121. Nhan, D. T., Cam, D. T., Wille, M., Defoirdt, T., Bossier, P., and Sorgeloos, P. (2010). Quorum quenching bacteria protect Macrobrachium rosenbergii larvae from Vibrio harveyi infection. J. Appl. Microbiol. 109, 1007-1016. doi: 10.1111/j.1365-2672.2010.04728.x
122. Nocek, B., Tikhonov, A., Babnigg, G., Gu, M., Zhou, M., Makarova, K. S., et al. (2012). Structural and functional characterization of microcin C resistance peptidase MccF from Bacillus anthracis. J. Mol. Biol. 420, 366-383. doi: 10.1016/j.jmb.2012.04.011
123. Nordfelth, R., Kauppi, A. M., Norberg, H. A., Wolf-Watz, H., and Elofsson, M. (2005). Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73, 3104-3114. doi: 10.1128/IAI.73.5.3104-3114.2005
124. Oetting, L. L., Utiyama, C. E., Giani, P. A., Ruiz, U. D., and Miyada, V. S. (2006). Effects of herbal extracts and antimicrobials on apparent digestibility, performance, organs morphometry and intestinal histology of weanling pigs. Braz. J. Anim. Sci. 35, 1389-1397. doi: 10.1590/S1516-35982006000500019
125. O'Flaherty, S., Coffey, A., Meaney, W., Fitzgerald, G. F., and Ross, R. P. (2005). The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J. Bacteriol. 187, 7161-7164. doi: 10.1128/JB.187.20.7161-7164.2005
126. O'Flaherty, S., Ross, R. P., and Coffey, A. (2009). Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol. Rev. 33, 801-819. doi: 10.1111/j.1574-6976.2009.00176.x
127. Ozer, E. A., Pezzulo, A., Shih, D. M., Chun, C., Furlong, C., Lusis, A. J., et al. (2005). Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing. FEMS Microbiol. Lett. 253, 29-37. doi: 10.1016/j.femsle.2005.09.023
128. Parks, W. M., Bottrill, A. R., Pierrat, O. A., Durrant, M. C., and Maxwell, A. (2007). The action of the bacterial toxin, microcin B17, on DNA gyrase. Biochimie 89, 500-507. doi: 10.1016/j.biochi.2006.12.005
129. Parsek, M. R., Val, D. L., Hanzelka, B. L., Cronan, J. E. Jr., and Greenberg, E. P. (1999). Acyl homoserine-lactone quorum-sensing signal generation. Proc. Natl. Acad. Sci. U.S.A. 96, 4360-4365. doi: 10.1073/pnas.96.8.4360
130. Paul, V. D., Rajagopalan, S. S., Sundarrajan, S., George, S. E., Asrani, J. Y., Pillai, R., et al. (2001). A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein. BMC Microbiol. 11:226. doi: 10.1186/1471-2180-11-226
131. Pereira, U. P., Oliveira, D. G., Mesquita, L. R., Costa, G. M., and Pereira, L. J. (2011). Efficacy of Staphylococcus aureus vaccines for bovine mastitis: a systematic review. Vet. Microbiol. 148, 117-124. doi: 10.1016/j.vetmic.2010.10.003
132. Peterson, M. M., Mack, J. L., Hall, P. R., Alsup, A. A., Alexander, S. M., Sully, E. K., et al. (2008). Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe 4, 555-566. doi: 10.1016/j.chom.2008.10.001
133. Pinkner, J. S., Remaut, H., Buelens, F., Miller, E., Aberg, V., Pemberton, N., et al. (2006). Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl. Acad. Sci. U.S.A. 103, 17897-17902. doi: 10.1073/pnas.0606795103
134. Piper, C., Draper, L. A., Cotter, P. D., Ross, R. P., and Hill, C. (2009). A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J. Antimicrob. Chemother. 64, 546-551. doi: 10.1093/jac/dkp221
135. Pirnay, J. P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., et al. (2011). The phage therapy paradigm: pret-a-porter or sur-mesure? Pharm. Res. 28, 934-937. doi: 10.1007/s11095-010-0313-5
136. Potter, A., Gerdts, V., and Littel-van den Hurk, S. (2008). Veterinary vaccines: alternatives to antibiotics? Anim. Health Res. Rev. 9, 187-199. doi: 10.1017/S1466252308001606
137. Qi, Q. G., and Wang, W. X. (2009). The research about Candida albicans biofilms eliminated by miconazole combined with drug efflux pump inhibitors. Chin. J. Microbiol. Immunol. 29, 113-116. doi: 10.3760/cma.j.issn.0254-5101.2009.02.004
138. Ralston, D. J., Baer, B. S., Lieberman, M., and Krueger, A. P. (1955). Virolysin: a virus-induced lysin from staphylococcal phage lysates. Proc. Soc. Exp. Biol. Med. 89, 502-507. doi: 10.3181/00379727-89-21859
139. Rashel, M., Uchiyama, J., Takemura, I., Hoshiba, H., Ujihara, T., Takatsuji, H., et al. (2008). Tail-associated structural protein gp61 of Staphylococcus aureus phage phi MR11 has bifunctional lytic activity. FEMS Microbiol. Lett. 284, 9-16. doi: 10.1111/j.1574-6968.2008.01152.x
140. Ravindran, V., and Son, J. H. (2011). Feed enzyme technology: present status and future developments. Recent Pat. Food Nutr. Agric. 3, 102-109. doi: 10.2174/2212798411103020102
141. Resch, A., Rosenstein, R., Nerz, C., and Gotz, F. (2005). Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl. Environ. Microbiol. 71, 2663-2676. doi: 10.1128/AEM.71.5.2663-2676.2005
142. Riede, I., and Eschbach, M. L. (1986). Evidence that TraT interacts with OmpA of Escherichia coli. FEBS Lett. 205, 241-245. doi: 10.1016/0014-5793(86)80905-X
143. Rodriguez, L., Martinez, B., Zhou, Y., Rodriguez, A., Donovan, D. M., and Garcia, P. (2011). Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol. 11:138. doi: 10.1186/1471-2180-11-138
144. Rodriguez-Rubio, L., Martinez, B., Donovan, D. M., Rodriguez, A., and Garcia, P. (2013). Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit. Rev. Microbiol. 39, 427-434. doi: 10.3109/1040841X.2012.723675
145. Rodriguez-Rubio, L., Martinez, B., Rodriguez, A., Donovan, D. M., and Garcia, P. (2012). Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl. Environ. Microbiol. 78, 2241-2248. doi: 10.1128/AEM.07621-11
146. Romero, M., Acuna, L., and Otero, A. (2012). Patents on quorum quenching: interfering with bacterial communication as a strategy to fight infections. Recent Pat. Biotechnol. 6, 2-12. doi: 10.2174/187220812799789208
147. Ruan, X., Liu, M., Casey, T. A., and Zhang, W. (2011). A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection. Clin. Vaccine Immunol. 18, 1593-1599. doi: 10.1128/CVI.05120-11
148. Sarica, S., Ciftci, A., Demir, E., Kilinc, K., and Yildirim, Y. (2005). Use of an antibiotic growth promoter and two herbal natural feed additives with and without exogenous enzymes in wheat based broiler diets. S. Afr. J. Anim. Sci. 35, 61-72.
149. Savoia, D. (2012). Plant-derived antimicrobial compounds: alternatives to antibiotics. Future Microbiol. 7, 979-990. doi: 10.2217/fmb.12.68
150. Scalbert, A. (1991). Antimicrobial properties of tannins. Phytochemistry 30, 3875-3883. doi: 10.1016/0031-9422(91)83426-L
151. Seal, B. S., Lillehoj, H. S., Donovan, D. M., and Gay, C. G. (2013). Alternatives to antibiotics: a symposium on the challenges and solutions for animal production. Anim. Health Res. Rev. 14, 78-87. doi: 10.1017/S1466252313000030
152. Selan, L., Berlutti, F., Passariello, C., Comodi-Ballanti, M. R., and Thaller, M. C. (1993). Proteolytic enzymes: a new treatment strategy for prosthetic infections? Antimicrob. Agents Chemother. 37, 2618-2621. doi: 10.1128/AAC.37.12.2618
153. Shin, J. R., Lim, K. J., Kim da, J., Cho, J. H., and Kim, S. C. (2013). Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics. PLoS ONE 8:e58997. doi: 10.1371/journal.pone.0058997
154. Shoop, W. L., Xiong, Y., Wiltsie, J., Woods, A., Guo, J., Pivnichny, J. V., et al. (2005). Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. U.S.A. 102, 7958-7963. doi: 10.1073/pnas.0502159102
155. Simoes, M., Bennett, R. N., and Rosa, E. A. (2009). Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat. Prod. Rep. 26, 746-757. doi: 10.1039/b821648g
156. Sintim, H. O., Smith, J. A., Wang, J., Nakayama, S., and Yan, L. (2010). Paradigm shift in discovering next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules. Future Med. Chem. 2, 1005-1035. doi: 10.4155/fmc.10.185
157. Slominski, B. A. (2011). Recent advances in research on enzymes for poultry diets. Poult. Sci. 90, 2013-2023. doi: 10.3382/ps.2011-01372
158. Smith, H. W., and Huggins, M. B. (1982). Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol. 128, 307-318.
159. Smulikowska, S., Czerwinski, J., and Mieczkowska, A. (2010). Effect of an organic acid blend and phytase added to a rapeseed cake-containing diet on performance, intestinal morphology, caecal microflora activity and thyroid status of broiler chickens. J. Anim. Physiol. Anim. Nutr. (Berl.) 94, 15-23. doi: 10.1111/j.1439-0396.2008.00876.x
160. Song, Y., La, T., Phillips, N. D., Bellgard, M. I., and Hampson, D. J. (2009). A reverse vaccinology approach to swine dysentery vaccine development. Vet. Microbiol. 137, 111-119. doi: 10.1016/j.vetmic.2008.12.018
161. Stanton, T. B. (2013). A call for antibiotic alternatives research. Trends Microbiol. 21, 111-113. doi: 10.1016/j.tim.2012.11.002
162. Stavri, M., Piddock, L. J., and Gibbons, S. (2007). Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 59, 1247-1260. doi: 10.1093/jac/dkl460
163. Sun, Z., Zhong, J., Liang, X., Liu, J., Chen, X., and Huan, L. (2009). Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR. Antimicrob. Agents Chemother. 53, 1964-1973. doi: 10.1128/AAC.01382-08
164. Swift, S., Downie, J. A., Whitehead, N. A., Barnard, A. M., Salmond, G. P., and Williams, P. (2001). Quorum sensing as a population-density-dependent determinant of bacterial physiology. Adv. Microb. Physiol. 45, 199-270. doi: 10.1016/S0065-2911(01)45005-3
165. Takac, M., and Blasi, U. (2005). Phage P68 virion-associated protein 17 displays activity against clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 49, 2934-2940. doi: 10.1128/AAC.49.7.2934-2940.2005
166. Tan, S., Gyles, C. L., and Wilkie, B. N. (1997). Evaluation of an aroA mutant Salmonella typhimurium vaccine in chickens using modified semisolid Rappaport Vassiliadis medium to monitor faecal shedding. Vet. Microbiol. 54, 247-254. doi: 10.1016/S0378-1135(96)01279-5
167. Tatara, M. R., Sliwa, E., Dudek, K., Gawron, A., Piersiak, T., Dobrowolski, P., et al. (2008). Aged garlic extract and allicin improve performance and gastrointestinal tract development of piglets reared in artificial sow. Ann. Agric. Environ. Med. 15, 63-69.
168. Thacker, E. L. (2010). Immunomodulators, immunostimulants, and immunotherapies in small animal veterinary medicine. Vet. Clin. North Am. Small Anim. Pract. 40, 473-483. doi: 10.1016/j.cvsm.2010.01.004
169. Upadrasta, A., O'Sullivan, L., O'Sullivan, O., Sexton, N., Lawlor, P. G., Hill, C., et al. (2013). The effect of dietary supplementation with spent cider yeast on the swine distal gut microbiome. PLoS ONE 8:e75714. doi: 10.1371/journal.pone.0075714
170. Vondruskova, H., Slamova, R., Trckova, M., Zraly, Z., and Pavlik, I. (2010). Alternatives to antibiotic growth promoters in prevention of diarrhoea in weaned piglets: a review. Vet. Med. 55, 199-224.
171. Williams, D. L., Mueller, A., and Browder, W. (1996). Glucan-based macrophage stimulators - a review of their anti-infective potential. Clin. Immunother. 5, 392-399. doi: 10.1007/BF03259335
172. Windisch, W., Schedle, K., Plitzner, C., and Kroismayr, A. (2008). Use of phytogenic products as feed additives for swine and poultry. J. Anim. Sci. 86(Suppl.), E140-E148. doi: 10.2527/jas.2007-0459
173. Wittebole, X., De Roock, S., and Opal, S. M. (2014). A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5, 226-235. doi: 10.4161/viru.25991
174. Xavier, K. B., and Bassler, B. L. (2005). Interference with AI-2-mediated bacterial cell-cell communication. Nature 437, 750-753. doi: 10.1038/nature03960
175. Yang, Y., Iji, P. A., and Choct, M. (2009). Dietary modulation of gut microflora in broiler chickens: a review of the role of six kinds of alternatives to in-feed antibiotics. Worlds Poult. Sci. 65, 97-114. doi: 10.1017/S0043933909000087
176. Yoong, P., Schuch, R., Nelson, D., and Fischetti, V. A. (2004). Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. 186, 4808-4812. doi: 10.1128/JB.186.14.4808-4812.2004
177. Young, J. A., and Collier, R. J. (2007). Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 76, 243-265. doi: 10.1146/annurev.biochem.75.103004.142728
178. Zanchi, R., Canzi, E., Molteni, L., and Scozzoli, M. (2008). Effect of Camellia sinensis L. whole plant extract on piglet intestinal ecosystem. Ann. Microbiol. 58, 147-152. doi: 10.1007/BF03179459
179. Zhang, W., and Sack, D. A. (2012). Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans. Expert Rev. Vaccines 11, 677-694. doi: 10.1586/erv.12.37